NCT02323334 A Study of LY3202626 in Healthy Participants and Participants With Alzheimer's Disease Status COMPLETED Phase PHASE1
NCT02314117 A Study of Ramucirumab (LY3009806) in Combination With Capecitabine and Cisplatin in Participants With Stomach Cancer Status COMPLETED Phase PHASE3
NCT02308020 A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the Brain Status COMPLETED Phase PHASE2
NCT02307812 Ramucirumab Use in Combination With Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma; Temporary Authorization for Use (ATU) in France Status APPROVED_FOR_MARKETING Phase N/A
NCT02304419 A Study of Galunisertib on the Immune System in Participants With Cancer Status COMPLETED Phase PHASE1
NCT02302716 A Study of LY2963016 Compared to LANTUS® in Adult Participants With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT02271425 A Study to Measure the Amount of Evacetrapib That Enters the Blood Stream in Healthy Participants Status COMPLETED Phase PHASE1
NCT02266472 Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Metformin Extended Release Compared With Mono Compound Tablets in Healthy Male and Female Status COMPLETED Phase PHASE1
NCT02265705 A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis (RA) Status COMPLETED Phase PHASE3
NCT02265536 A Study of LY3022855 In Participants With Breast or Prostate Cancer Status COMPLETED Phase PHASE1
NCT02260648 A Study of Evacetrapib (LY2484595) in Combination With Atorvastatin in Japanese Participants With Primary Hypercholesterolemia Status TERMINATED Phase PHASE3
NCT02260635 A Study of Evacetrapib (LY2484595) in Japanese Participants With Primary Hypercholesterolemia Status TERMINATED Phase PHASE3
NCT02252367 Effect of 12 Weeks Treatment With Tadalafil vs Placebo on Lower Urinary Tract Symptoms Status COMPLETED Phase PHASE4
NCT02248480 A Study of Duloxetine (LY248686) in Participants With Chronic Osteoarthritis and Knee Pain in Japan Status COMPLETED Phase PHASE3
NCT02246621 A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3